Delivery Order SPE2DB24D3015-SPE2DB25FGBBM
- Not listed
- The Defense Logistics Agency awarded a $19,860.97 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on June 26, 2025, with completion expected by June 27, 2025. This firm fixed-price contract represents a non-competitive set-aside and reflects AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs. The order is being performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $63,121.17 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, carries no set-aside designation and represents a competitively awarded procurement. AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $13,341.78 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count). The contract, executed on June 25, 2025, with an ultimate completion date of June 26, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its Corporate Office division. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $33,622.40 for the supply of Otezla 30 mg tablets (60-count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the company's distribution center in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,642.74 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $7,076.11 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packaging) on December 1, 2025, with completion expected by December 2, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract (IDC) vehicle—specifically the DLA Troop Support Medical contract SPE2DX valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $12,445.76 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $7,764.93 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) with a completion date of August 20, 2025. This competitive award, issued on August 19, 2025, carries firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,048.55 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $63,173.01 delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGBBMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $26,545.59 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed price contract. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This contract vehicle provides critical access to specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The arrangement allows the Defense Logistics Agency to efficiently procure pharmaceutical products for Defense Health Agency customers, the U.S. Coast Guard, and other federal healthcare systems through a flexible and established vendor relationship with a major pharmaceutical distributor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 9/22/25 |